Mirum Pharmaceuticals (MIRM) Times Interest Earned (2019 - 2026)
Mirum Pharmaceuticals' (MIRM) quarterly Times Interest Earned came in at -$29.52 in Q1 2026, down 25450.14% year-on-year from N/an in Q1 2025, and down 5112.65% quarter-over-quarter from -$0.57 in Q4 2025.
Mirum Pharmaceuticals (MIRM) Times Interest Earned (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Times Interest Earned history runs 8 years deep, the most recent figure standing at -$29.52 for Q1 2026.
- On a quarterly basis, Times Interest Earned fell 25450.14% year-over-year to -$29.52 in Q1 2026; TTM through Mar 2026 was -$29.78, a 5027.61% decrease from a year earlier, with the FY2025 full-year figure at -$0.05, up 87.73% from the prior year.
- Times Interest Earned eased to -$29.52 in Q1 2026 per MIRM's latest filing, from -$0.57 in the prior quarter.
- Across five years, Times Interest Earned topped out at $0.02 in Q3 2025 and bottomed at -$29.52 in Q1 2026.
- The 5-year median for Times Interest Earned is -$0.8 (2023), against an average of -$3.62.
- Across the five-year window, Times Interest Earned soared 124.2% in 2025 and sank 25450.14% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$7.84 in 2022, then soared by 70.89% to -$2.28 in 2023, then tumbled by 196.61% to -$6.77 in 2024, then surged by 91.63% to -$0.57 in 2025, then slumped by 5112.65% to -$29.52 in 2026.
- Per Business Quant, the three latest MIRM Times Interest Earned figures stand at -$29.52 (Q1 2026), -$0.57 (Q4 2025), and $0.02 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Mirum Pharmaceuticals | 6.73 Bn | 6.34 Bn | 131.08 Mn | -29.52 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.52 |
| Dec 31, 2025 | -0.57 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.12 |
| Dec 31, 2024 | -6.77 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | -1.03 |
| Mar 31, 2024 | -0.18 |
| Dec 31, 2023 | -2.28 |
| Sep 30, 2023 | -0.15 |
| Jun 30, 2023 | -0.72 |
| Mar 31, 2023 | -0.80 |
| Dec 31, 2022 | -7.84 |
| Sep 30, 2022 | -7.89 |
| Jun 30, 2022 | -1.15 |
| Mar 31, 2022 | -2.42 |
| Dec 31, 2021 | -12.10 |
| Sep 30, 2021 | -7.51 |
| Jun 30, 2021 | -7.79 |